Clinical Guidelines Portal

Home > Guidelines > Adult and Adolescent Treatment Guidelines > Panel Roster
Text Size
Search

Guideline Search

Type your search term(s) in the text box. Users can only search one guideline at a time. To search for an exact phrase, use quotation marks (i.e. "what to start"). To narrow your search, add additional relevant terms. If you are not finding what you need, try searching similar terms (i.e. perinatal OR pregnancy) to broaden your search.

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

Panel Roster

(Last updated:3/27/2012; last reviewed:3/27/2012)

Printer-Friendly Files

HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Panel Roster

These Guidelines were developed by the Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents (a Working Group of the Office of AIDS Research Advisory Council).

Panel Co-Chairs
John G. Bartlett

Johns Hopkins University, Baltimore, MD

H. Clifford Lane

National Institutes of Health, Bethesda, MD

Executive Secretary

Alice K. Pau

National Institutes of Health, Bethesda, MD

Scientific Members

John T. Brooks

Centers for Disease Control and Prevention, Atlanta, GA

Deborah L. Cohan

University of California–San Francisco, San Francisco, CA

Eric Daar 

University of California–Los Angeles, Harbor-UCLA Medical Center,Los Angeles, CA

Steven G. Deeks

University of California–San Francisco, San Francisco, CA

Carlos del Rio

Emory University, Atlanta, GA

Robert T. Dodge

University of North Carolina, Chapel Hill, NC

Courtney V. Fletcher

University of Nebraska Medical Center, Omaha, NE

Gerald Friedland

Yale University School of Medicine, New Haven, CT

Joel E. Gallant

Johns Hopkins University, Baltimore, MD

Stephen J. Gange

Johns Hopkins University, Baltimore, MD

Christopher M. Gordon

National Institutes of Health, Bethesda, MD

Roy M. Gulick

Weill Medical College of Cornell University, New York, NY

W. Keith Henry

Hennepin County Medical Center & University of Minnesota, Minneapolis, MN

Martin S. Hirsch

Massachusetts General Hospital & Harvard Medical School, Boston, MA

Michael D. Hughes

Harvard School of Public Health, Boston, MA

Bill G. Kapogiannis

National Institutes of Health, Bethesda, MD

Daniel R. Kuritzkes

Brigham and Women’s Hospital & Harvard Medical School, Boston, MA

Richard W. Price

University of California–San Francisco, San Francisco, CA

Michael Saag

University of Alabama at Birmingham, Birmingham, AL

Paul Sax

Brigham and Women’s Hospital & Harvard Medical School, Boston, MA

Mark Sulkowski

Johns Hopkins University, Baltimore, MD

Zelalem Temesgen

Mayo Clinic, Rochester, MN

David A. Wohl

University of North Carolina, Chapel Hill, NC

Community Members

Lei Chou

Treatment Action Group, New York, NY

Paul Dalton

San Francisco, CA

Heidi Nass

Madison, WI

Jeff Taylor

AIDS Treatment Activists Coalition, Palm Springs, CA

Nelson Vergel

Program for Wellness Restoration, Houston, TX

Members Representing Department of Health and Human Services Agencies

Victoria Cargill

National Institutes of Health, Rockville, MD

Laura Cheever

Health Resources and Services Administration, Rockville, MD

Jonathan Kaplan

Centers for Disease Control and Prevention, Atlanta, GA

Kendall Marcus

Food and Drug Administration, Silver Spring, MD

Henry Masur

National Institutes of Health, Bethesda, MD

Lynne Mofenson

National Institutes of Health, Bethesda, MD

Kimberly Struble 

Food and Drug Administration, Silver Spring, MD

Non-Voting Observer

Monica Calderon 

National Institutes of Health, SAIC-Frederick, Inc., NCI-Frederick, Frederick, MD

Acknowledgement

The Panel would like to acknowledge the assistance of Sarita D. Boyd, Pharm.D., (Food and Drug Administration) for her assistance in updating the drug interaction tables and Satish Gopal, M.D., Ph.D., (University of North Carolina) and Ronald Mitsuyasu, M.D., (University of California–Los Angeles) for their assistance with the “Malignancies” discussion in Initiating Antiretroviral Therapy.